Real-time enrollment status for this epidermolysis bullosa simplex clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 2:01 PM UTC
| NCT Number | NCT07027345 |
| Recruiting Status | Recruiting |
| Condition | Epidermolysis Bullosa Simplex |
| Phase | Clinical Trial |
| Target Enrollment | 40 participants |
| Active Locations | 2 sites in the US |
| Sponsor | BioMendics, LLC |
| Last Updated on CT.gov | September 11, 2025 (Sep 11, 2025) |
As of March 2, 2026: Clinical trial NCT07027345 is currently recruiting participants. This clinical trial study for epidermolysis bullosa simplex is actively seeking new participants at 2 locations across the United States. The study is sponsored by BioMendics, LLC. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07027345 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 2 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07027345 was last updated Sep 11, 2025 (September 11, 2025). HelloStudys verifies this status automatically.